CHAPTER 1: INTRODUCTION

1.1. Report description

1.1.1. Key benefits for stakeholders
1.1.2. Key market segments

1.2. Research methodology

1.2.1. Secondary research
1.2.2. Primary research
1.2.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top player positioning, 2019
3.2.3. Key forces shaping the global ophthalmic devices market

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Rise in prevalence of eye-related diseases worldwide
3.3.1.2. Rapid technological advancements in ophthalmic
3.3.1.3. Increase in focus on customer training and education along with awareness
3.3.1.4. High adoption of digital devices worldwide

3.3.2. Restraints

3.3.2.1. Low awareness about eye-related diseases
3.3.2.2. Dearth of skilled professionals53

3.3.3. Opportunities

3.3.3.1. Potential growth opportunities in emerging nations for ophthalmic devices manufacturers

3.4. GOVERNMENT REGULATIONS

3.4.1. FDA
3.4.2. CE Mark
3.4.3. Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)

CHAPTER 4: OPTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION

4.1. Overview

4.1.1. Market size and forecast, by region

4.2. Surgical devices

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Refractive error surgical devices

4.2.3.1. Market size and forecast

4.2.4. Glaucoma surgical devices

4.2.4.1. Market size and forecast

4.2.5. Cataract surgical devices

4.2.5.1. Market size and forecast

4.2.6. Vitreoretinal surgical devices

4.2.6.1. Market size and forecast

4.3. Diagnostic devices

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Refractors

4.3.3.1. Market size and forecast

4.3.4. Corneal topography systems

4.3.4.1. Market size and forecast

4.3.5. Retinal ultrasound systems

4.3.5.1. Market size and forecast

4.3.6. Fundus camera

4.3.6.1. Market size and forecast

4.3.7. Ophthalmoscopes

4.3.7.1. Market size and forecast

4.3.8. Optical coherence tomography systems

4.3.8.1. Market size and forecast

4.3.9. Perimeters

4.3.9.1. Market size and forecast

4.3.10. Slit lamps

4.3.10.1. Market size and forecast

4.3.11. Tonometer

4.3.11.1. Market size and forecast

4.4. Vision care devices

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Contact lenses

4.4.3.1. Market size and forecast

4.4.4. Spectacle lenses

4.4.4.1. Market size and forecast

CHAPTER 5: OPHTHALMIC DEVICES MARKET, BY REGION

5.1. Overview

5.1.1. Market size and forecast

5.2. North America

5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by product function
5.2.3. Market size and forecast, by region
5.2.4. U.S.

5.2.4.1. Market size and forecast, by product function

5.2.5. Canada

5.2.5.1. Market size and forecast, by product function

5.2.6. Mexico

5.2.6.1. Market size and forecast, by product function

5.3. Europe

5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by product function
5.3.3. Market size and forecast, by region
5.3.4. Germany

5.3.4.1. Market size and forecast, by product function

5.3.5. France

5.3.5.1. Market size and forecast, by product function

5.3.6. UK

5.3.6.1. Market size and forecast, by product function

5.3.7. Italy

5.3.7.1. Market size and forecast, by product function

5.3.8. Spain

5.3.8.1. Market size and forecast, by product function

5.3.9. Rest of the Europe

5.3.9.1. Market size and forecast, by product function

5.4. Asia-Pacific

5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by product function
5.4.3. Market size and forecast, by region
5.4.4. Japan

5.4.4.1. Market size and forecast, by product function

5.4.5. China

5.4.5.1. Market size and forecast, by product function
5.4.6. Australia market size and forecast
5.4.6.1. Market size and forecast, by product function

5.4.7. India

5.4.7.1. Market size and forecast, by product function

5.4.8. Rest of Asia-Pacific

5.4.8.1. Market size and forecast, by product function

5.5. LAMEA

5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by product function
5.5.3. Market size and forecast, by region
5.5.4. Brazil

5.5.4.1. Market size and forecast, by product function

5.5.5. Saudi Arabia market size and forecast

5.5.5.1. Market size and forecast, by product function

5.5.6. South Africa

5.5.6.1. Market size and forecast, by product function

5.5.7. Rest of LAMEA

5.5.7.1. Market size and forecast, by product function

CHAPTER 6: COMPANY PROFILES

6.1. Carl Zeiss Meditec AG

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments

6.2. Essilor International S.A.

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.2.6. Key strategic moves and developments

6.3. Haag-Streit holding Ag

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments

6.4. Hoya Corporation

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Business performance
6.4.5. Key strategic moves and developments

6.5. Johnson & Johnson

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.5.6. Key strategic moves and developments

6.6. NIDEK CO., LTD.

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Key strategic moves & developments

6.7. Novartis AG (ALCON-a division of Novartis)

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance

6.8. Topcon Corporation

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments
6.8.4. Product portfolio
6.8.5. Business performance

6.9. Bausch Health Companies Inc.

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance

6.10. Ziemer Ophthalmic Systems AG

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Product portfolio

6.11. List of mergers and acquisitions (M&A) activities